SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Siyan Chen, Xia Lu, Wanli Zhang, Zhao Han, Wen Yang, Xuerong Huang, Xiaoping Jin, Zhimin Wang, Haiyan Liang, Weiwen Qiu, Jianhua Cheng, Bei Shao, Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients?, Journal of Stroke and Cerebrovascular Diseases, 2016,

    CrossRef

  2. 2
    Shunsuke Tanoue, Joji Inamasu, Masayuki Yamada, Hiroshi Toyama, Yuichi Hirose, Does Dabigatran Increase the Risk of Delayed Hematoma Expansion in a Rat Model of Collagenase-induced Intracerebral Hemorrhage?, Journal of Stroke and Cerebrovascular Diseases, 2015, 24, 2, 374

    CrossRef

  3. 3
    Jafna L. Cox, Effective practical management of patients with atrial fibrillation when using new oral anticoagulants, Annals of Medicine, 2015, 47, 4, 278

    CrossRef

  4. 4
    Adrian Marchidann, Clotilde Balucani, Steven R. Levine, Expansion of Intravenous Tissue Plasminogen Activator Eligibility Beyond National Institute of Neurological Disorders and Stroke and European Cooperative Acute Stroke Study III Criteria, Neurologic Clinics, 2015, 33, 2, 381

    CrossRef

  5. 5
    Corina Epple, Thorsten Steiner, Acute stroke in patients on new direct oral anticoagulants: how to manage, how to treat?, Expert Opinion on Pharmacotherapy, 2014, 15, 14, 1991

    CrossRef

  6. 6
    L. Derex, L. Mechtouff, Anticoagulants oraux directs, fibrillation atriale et accidents vasculaires cérébraux, Pratique Neurologique - FMC, 2014, 5, 4, 269

    CrossRef

  7. 7
    Graeme J. Hankey, Intracranial Hemorrhage and Novel Anticoagulants for Atrial Fibrillation: What Have We Learned?, Current Cardiology Reports, 2014, 16, 5

    CrossRef

  8. 8
    Syoichiro Kono, Kentaro Deguchi, Yoshio Omote, Taijun Yunoki, Toru Yamashita, Tomoko Kurata, Yoshio Ikeda, Koji Abe, Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat, Journal of Neuroscience Research, 2014, 92, 1
  9. 9
    Robert Ploen, Li Sun, Wei Zhou, Stefan Heitmeier, Markus Zorn, Ekkehart Jenetzky, Roland Veltkamp, Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke, Journal of Cerebral Blood Flow & Metabolism, 2014, 34, 3, 495

    CrossRef

  10. 10
    Akira Ito, Kuniyasu Niizuma, Hiroaki Shimizu, Miki Fujimura, Keiji Hasumi, Teiji Tominaga, SMTP-7, a new thrombolytic agent, decreases hemorrhagic transformation after transient middle cerebral artery occlusion under warfarin anticoagulation in mice, Brain Research, 2014, 1578, 38

    CrossRef

  11. 11
    Luiz Carlos Porcello Marrone, Antônio Carlos Huf Marrone, Acute Ischemic Stroke and New Anticoagulants – How to Act in the Acute Phase of Stroke, Cerebrovascular Diseases, 2013, 35, 1, 91

    CrossRef

  12. 12
    L. Sun, W. Zhou, R. Ploen, M. Zorn, R. Veltkamp, Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia, Thrombosis and Haemostasis, 2013, 110, 1, 153

    CrossRef

  13. 13
    José Álvarez-Sabín, Olga Maisterra, Estevo Santamarina, Carlos S Kase, Factors influencing haemorrhagic transformation in ischaemic stroke, The Lancet Neurology, 2013, 12, 7, 689

    CrossRef

  14. 14
    Tarek Y. El Ahmadieh, Salah G. Aoun, Marc R. Daou, Najib E. El Tecle, Rudy J. Rahme, Randall B. Graham, Joseph G. Adel, H. Hunt Batjer, Bernard R. Bendok, New-generation oral anticoagulants for the prevention of stroke: Implications for neurosurgery, Journal of Clinical Neuroscience, 2013, 20, 10, 1350

    CrossRef

  15. You have free access to this content15
    S. Jayathissa, J. Gommans, P. Harper, Stroke thrombolysis in patients taking dabigatran, Internal Medicine Journal, 2013, 43, 7
  16. 16
    Hans-Christoph Diener, Christian Foerch, Hanno Riess, Joachim Röther, Gerhard Schroth, Ralph Weber, Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment, The Lancet Neurology, 2013, 12, 7, 677

    CrossRef

  17. 17
    Igor Rybinnik, Michael T. Mullen, Steven Messe, Scott E. Kasner, Brett Cucchiara, Treatment of Acute Stroke in Patients on Dabigatran: A Survey of US Stroke Specialists, Journal of Stroke and Cerebrovascular Diseases, 2013, 22, 8, 1312

    CrossRef

  18. 18
    G. J. Hankey, Unanswered questions and research priorities to optimise stroke prevention in atrial fibrillation with the new oral anticoagulants, Thrombosis and Haemostasis, 2013, 111, 5, 808

    CrossRef

  19. 19
    Mark Fisher, Vitaly Vasilevko, David H. Cribbs, Mixed Cerebrovascular Disease and the Future of Stroke Prevention, Translational Stroke Research, 2012, 3, S1, 39

    CrossRef

  20. 20
    Hans-Christoph Diener, Thrombolyse bei oraler Antikoagulation, InFo Neurologie & Psychiatrie, 2012, 14, 6, 34

    CrossRef

  21. 21
    Luiz Carlos Porcello Marrone, Antônio Carlos Huf Marrone, Thrombolysis in an Ischemic Stroke Patient on Dabigatran Anticoagulation: A Case Report, Cerebrovascular Diseases, 2012, 34, 3, 246

    CrossRef